Aurora Cannabis Inc. (ACB)

Market Cap	333.29M
Revenue (ttm)	203.84M
Net Income (ttm)	-23.50M
Shares Out	54.66M
EPS (ttm)	-0.50
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,187,927
Open	5.50
Previous Close	5.51
Day's Range	5.49 - 6.23
52-Week Range	2.84 - 9.35
Beta	2.71
Analysts	Hold
Price Target	n/a
Earnings Date	Nov 7, 2024

About ACB

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2013
• Employees: 1,073
• Stock Exchange: NASDAQ
• Ticker Symbol: ACB
• Website: https://www.auroramj.com

Financial Performance

In 2023, Aurora Cannabis's revenue was 270.28 million, an increase of 20.77% compared to the previous year's 223.80 million. Losses were -65.58 million, -91.97% less than in 2022.

Financial numbers in CAD